Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

1,174 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Hepatectomy Followed by Adjuvant Chemotherapy with 3-Month Capecitabine Plus Oxaliplatin for Colorectal Cancer Liver Metastases.
Satake H, Hashida H, Tanioka H, Miyake Y, Yoshioka S, Watanabe T, Matsuura M, Kyogoku T, Inukai M, Kotake T, Okita Y, Matsumoto T, Yasui H, Kotaka M, Kato T, Kaihara S, Tsuji A. Satake H, et al. Among authors: yoshioka s. Oncologist. 2021 Jul;26(7):e1125-e1132. doi: 10.1002/onco.13816. Epub 2021 May 31. Oncologist. 2021. PMID: 33977607 Free PMC article.
Interim analysis of a phase II trial evaluating the safety and efficacy of capecitabine plus oxaliplatin (XELOX) as adjuvant therapy in Japanese patients with operated stage III colon cancer.
Danno K, Hata T, Tamai K, Fujie Y, Ide Y, Kim HM, Ohnishi T, Morita S, Yoshioka S, Kudo T, Nishimura J, Matsuda C, Akamatsu H, Mizushima T, Nezu R, Doki Y, Mori M; Multi-Center Clinical Study Group of Osaka; Colorectal Cancer Treatment Group (MCSGO). Danno K, et al. Among authors: yoshioka s. Cancer Chemother Pharmacol. 2017 Oct;80(4):777-785. doi: 10.1007/s00280-017-3419-1. Epub 2017 Aug 19. Cancer Chemother Pharmacol. 2017. PMID: 28825216 Clinical Trial.
Phase II trial of capecitabine plus oxaliplatin (CAPOX) as perioperative therapy for locally advanced rectal cancer.
Nishimura J, Hasegawa J, Kato T, Yoshioka S, Noura S, Kagawa Y, Yasui M, Ikenaga M, Murata K, Hata T, Matsuda C, Mizushima T, Yamamoto H, Doki Y, Mori M; Clinical Study Group of Osaka University (CSGO) Colorectal Group. Nishimura J, et al. Among authors: yoshioka s. Cancer Chemother Pharmacol. 2018 Oct;82(4):707-716. doi: 10.1007/s00280-018-3663-z. Epub 2018 Aug 4. Cancer Chemother Pharmacol. 2018. PMID: 30078098 Clinical Trial.
1,174 results